Company / Operating Cash Flow per Share
Xeris Biopharma Holdings, Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.19
FY2025
5-year range
-$2.24 / $0.19
FY2021-FY2025
Trend
+171.6%
vs FY2024
Sector context
#69 of 212
Health Care
What the data says
At $0.19, Xeris Biopharma Holdings, Inc.'s operating cash flow per share ranks #69 of 212 in the Health Care sector. Operating Cash Flow per Share has increased for 4 consecutive years, from $-2.24 in FY2021 to $0.19 in FY2025.
Based on SEC 10-K filings.
0.19 in FY2025.
Improved from $-0.35 to $0.19 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#69 of 212 in Health CareTop 33% of 212This company $0.19 Sector average -$14.72
▼
+101.3% above sector average
Key checks
Key Insights
- Xeris Biopharma Holdings, Inc.'s operating cash flow per share has grown for 4 consecutive years.
- In FY2025, operating cash flow per share increased 171.6% year-over-year.
- Ranks #69 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.19 | +171.6% |
| FY2024 | -$0.27 | +22.4% |
| FY2023 | -$0.35 | +54.9% |
| FY2022 | -$0.77 | +65.9% |
| FY2021 | -$2.24 | -18.6% |
| FY2020 | -$1.89 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026